(GRFS) Grifols - Performance 3.4% in 12m
Compare GRFS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-63.61%
#97 in Group
Rel. Strength
46.80%
#4245 in Universe
Total Return 12m
3.39%
#52 in Group
Total Return 5y
-63.21%
#72 in Group
P/E 27.2
64th Percentile in Group
P/E Forward 11.2
42th Percentile in Group
PEG 0.23
67th Percentile in Group
FCF Yield 4.58%
83th Percentile in Group
12m Total Return: GRFS (3.4%) vs XBI (-5.4%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: GRFS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for GRFS
Total Return (including Dividends) | GRFS | XBI | S&P 500 |
---|---|---|---|
1 Month | 0.86% | 5.55% | -0.45% |
3 Months | 6.04% | -9.75% | -6.29% |
12 Months | 3.39% | -5.39% | 13.04% |
5 Years | -63.21% | -13.20% | 111.82% |
Trend Score (consistency of price movement) | GRFS | XBI | S&P 500 |
1 Month | 36.3% | 70% | 47.5% |
3 Months | -25.0% | -88.1% | -87.3% |
12 Months | -3.40% | -44.4% | 54.3% |
5 Years | -85.0% | -53.6% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #124 | -4.44% | 1.31% |
3 Month | #39 | 17.5% | 13.2% |
12 Month | #51 | 9.28% | -8.54% |
5 Years | #75 | -57.6% | -82.6% |
FAQs
Does GRFS Grifols outperforms the market?
Yes,
over the last 12 months GRFS made 3.39%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months GRFS made 6.04%, while XBI made -9.75%.
Over the last 3 months GRFS made 6.04%, while XBI made -9.75%.
Performance Comparison GRFS vs Indeces and Sectors
GRFS vs. Indices GRFS is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -4.38% | 1.31% | -19.0% | -9.65% |
US NASDAQ 100 | QQQ | -5.30% | -1.04% | -19.7% | -11.6% |
US Dow Jones Industrial 30 | DIA | -3.84% | 3.71% | -18.3% | -5.88% |
German DAX 40 | DAX | -4.02% | 1.08% | -37.1% | -21.6% |
Shanghai Shenzhen CSI 300 | CSI 300 | -0.73% | 4.07% | -15.3% | -1.58% |
Hongkong Hang Seng | HSI | -3.98% | 2.38% | -19.5% | -9.54% |
India NIFTY 50 | INDA | -1.86% | -4.02% | -18.9% | 0.49% |
Brasil Bovespa | EWZ | -2.75% | -1.97% | -24.7% | 10.1% |
GRFS vs. Sectors GRFS is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -4.53% | 1.46% | -25.0% | -20.1% |
Consumer Discretionary | XLY | -4.41% | 1.45% | -20.2% | -11.3% |
Consumer Staples | XLP | -2.32% | 1.68% | -23.1% | -7.55% |
Energy | XLE | -0.12% | 14.9% | -13.9% | 12.7% |
Financial | XLF | -3.27% | 2.87% | -25.9% | -19.3% |
Health Care | XLV | -1.68% | 5.53% | -13.9% | 4.62% |
Industrial | XLI | -4.70% | 0.56% | -20.1% | -7.30% |
Materials | XLB | -2.57% | 4.08% | -11.2% | 7.83% |
Real Estate | XLRE | -4.27% | 1.96% | -19.2% | -15.0% |
Technology | XLK | -5.94% | -1.57% | -16.1% | -7.05% |
Utilities | XLU | -3.10% | 0.76% | -23.4% | -17.4% |
Aerospace & Defense | XAR | -5.41% | -6.12% | -32.9% | -24.1% |
Biotech | XBI | -4.22% | -4.69% | -3.70% | 8.78% |
Homebuilder | XHB | -3.11% | 2.94% | -4.05% | 9.56% |
Retail | XRT | -3.14% | 2.02% | -13.1% | 4.90% |